IT8448983A1 - Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina - Google Patents

Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Info

Publication number
IT8448983A1
IT8448983A1 IT1984A48983A IT4898384A IT8448983A1 IT 8448983 A1 IT8448983 A1 IT 8448983A1 IT 1984A48983 A IT1984A48983 A IT 1984A48983A IT 4898384 A IT4898384 A IT 4898384A IT 8448983 A1 IT8448983 A1 IT 8448983A1
Authority
IT
Italy
Prior art keywords
uridine
treatment
pharmaceutical agent
active pharmaceutical
cerebral disorders
Prior art date
Application number
IT1984A48983A
Other languages
English (en)
Other versions
IT1178044B (it
IT8448983A0 (it
Original Assignee
Polifarma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma Spa filed Critical Polifarma Spa
Priority to IT48983/84A priority Critical patent/IT1178044B/it
Publication of IT8448983A0 publication Critical patent/IT8448983A0/it
Priority to EP85830247A priority patent/EP0178267A3/en
Publication of IT8448983A1 publication Critical patent/IT8448983A1/it
Application granted granted Critical
Publication of IT1178044B publication Critical patent/IT1178044B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT48983/84A 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina IT1178044B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
EP85830247A EP0178267A3 (en) 1984-10-09 1985-10-02 a uridine-based pharmaceutically active agent for the treatment of cerebral pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Publications (3)

Publication Number Publication Date
IT8448983A0 IT8448983A0 (it) 1984-10-09
IT8448983A1 true IT8448983A1 (it) 1986-04-09
IT1178044B IT1178044B (it) 1987-09-03

Family

ID=11269269

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Country Status (2)

Country Link
EP (1) EP0178267A3 (it)
IT (1) IT1178044B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321994C (en) * 1987-10-28 1993-09-07 Reid Von Borstel Acylated uridine and cytidine and uses thereof
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
IT1219667B (it) * 1988-06-21 1990-05-24 Polifarma Spa Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5962459A (en) * 1996-05-28 1999-10-05 Polifarma S.P.A. Therapeutic active agent for treatment of neuron degenerative diseases
IT1290781B1 (it) * 1996-05-28 1998-12-10 Polifarma Spa Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
DK1140104T3 (da) * 1998-07-31 2008-01-21 Massachusetts Inst Technology Behandling af Alzheimer's sygdom ved forögelse af cytidinniveauer in vivo
US8314064B2 (en) * 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
BRPI0817387A2 (pt) 2007-11-02 2015-09-08 Massachusetts Inst Technology métodos de conformidade de suplementação dietária de uridina e uso dos mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4260M (it) * 1964-11-18 1966-07-04

Also Published As

Publication number Publication date
EP0178267A3 (en) 1988-09-21
IT1178044B (it) 1987-09-03
IT8448983A0 (it) 1984-10-09
EP0178267A2 (en) 1986-04-16

Similar Documents

Publication Publication Date Title
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
IT1184271B (it) Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
IT8448983A1 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
IT8547928A0 (it) Composizioni farmaceutiche stabili di agenti di blocco dei recettori beta-adrenergici per la profilassi ed il trattamento di disordini cardiaci
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
GB2165453B (en) Pharmaceutical agent for the local treatment of psoriasis
NO170012C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
ZA86370B (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.
NO853525L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.